Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alvotech, Angion, Aruvant, Astrazeneca, Atyr, Avillion, Blade, BMS, Boehringer, Immunicum, Neoleukin, Pharnext, Prota, Puretech, Recordati, Rocket, Synairgen, Urovant.